CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist
  • 36.30
  • +3.40+10.33%
Market Closed Sep 30 15:00 CST
18.30BMarket Cap80.49P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
67.53%3.25B
8.73%1.86B
28.07%1.96B
22.16%1.34B
92.75%1.94B
91.83%1.71B
-3.29%1.53B
1.48%1.1B
39.13%1.01B
33.36%891.97M
Transactional financial assets
-26.44%2.24B
15.00%3.71B
5.28%3.36B
7.89%3.77B
-11.66%3.05B
-5.16%3.22B
18.29%3.19B
271.41%3.49B
263.73%3.45B
--3.4B
Notes receivable and accounts receivable
-29.57%322.24M
-49.14%240.86M
-54.56%209.84M
-51.19%258.06M
-20.01%457.52M
-10.76%473.59M
1.63%461.8M
4.13%528.75M
12.63%571.98M
-6.30%530.68M
-Notes receivable
--2.6M
----
----
----
----
----
-99.02%91.9K
----
----
----
-Accounts receivable
-30.14%319.64M
-49.14%240.86M
-54.55%209.84M
-51.19%258.06M
-20.01%457.52M
-10.76%473.59M
3.74%461.71M
12.36%528.75M
32.76%571.98M
13.29%530.68M
Other receivables (including interest and dividends)
278.34%191.11M
81.96%154.41M
162.77%264.4M
324.51%354.26M
-53.13%50.51M
-6.79%84.86M
48.20%100.62M
36.19%83.45M
74.29%107.77M
72.27%91.04M
-Other receivable
278.34%191.11M
----
162.77%264.4M
----
-53.13%50.51M
----
48.20%100.62M
----
74.29%107.77M
----
Advance payment
-67.93%2.98M
-58.98%2.62M
-51.67%4.67M
-36.20%3.43M
130.49%9.29M
-28.52%6.39M
-25.75%9.66M
-56.44%5.38M
-63.08%4.03M
-98.69%8.94M
Inventories
-0.80%577.32M
-8.30%566.51M
-16.50%556.94M
-11.76%579.7M
-11.86%581.97M
-7.83%617.82M
-1.46%666.96M
7.09%656.93M
0.36%660.29M
-2.49%670.31M
Receivable financing
-41.02%58.46M
-35.05%77.35M
-37.20%66.08M
-40.90%73.52M
3.36%99.12M
6.40%119.1M
-21.28%105.22M
2.56%124.41M
11.30%95.91M
32.18%111.94M
Other current assets
-74.24%320.58K
39.18%2.61M
-50.82%1.77M
-67.18%638.47K
348.01%1.24M
-87.80%1.88M
-78.09%3.59M
-87.48%1.95M
-98.18%277.81K
-2.63%15.37M
Total current assets
7.40%6.65B
5.99%6.61B
5.83%6.43B
6.48%6.38B
4.94%6.19B
9.07%6.24B
7.57%6.07B
78.59%5.99B
95.78%5.9B
107.22%5.72B
Non Current assets
Other non-current financial assets
-24.85%91M
-22.76%92.37M
-14.26%100.39M
-10.68%111.84M
-8.68%121.09M
-12.50%119.59M
-19.23%117.09M
--125.21M
--132.59M
--136.67M
Investment real estate
-7.52%623.83K
-12.73%636.42K
-7.30%649.01K
--661.76K
--674.52K
--729.27K
--700.08K
----
----
----
Fixed assets
-1.66%607.7M
----
-0.88%634.23M
----
-9.60%617.95M
----
-10.67%639.88M
----
-5.18%683.59M
----
Constru in process
-38.87%55.27M
----
-42.41%39.94M
----
61.02%90.41M
----
69.72%69.34M
----
-14.17%56.15M
----
Intangible assets
-16.21%267.21M
-13.80%265.81M
-13.73%269.31M
17.66%313.77M
95.42%318.89M
85.42%308.35M
84.21%312.17M
36.56%266.67M
-15.15%163.19M
-15.10%166.3M
Development expenditure
29.91%61.19M
34.50%55.93M
40.49%53.22M
14.25%54.49M
-59.09%47.1M
-61.34%41.58M
-63.32%37.88M
-66.24%47.7M
-13.89%115.14M
-11.75%107.56M
Goodwill
-89.06%72.61M
-89.06%72.61M
-89.06%72.61M
-25.02%497.77M
0.00%663.84M
0.00%663.84M
0.00%663.84M
0.00%663.84M
0.00%663.84M
0.00%663.84M
Long deferred expense
-23.87%31.32M
-23.80%33.01M
-21.95%34.93M
7.47%50.53M
-18.33%41.14M
-20.25%43.32M
-23.28%44.76M
-20.53%47.02M
-12.17%50.37M
16.36%54.32M
Deferred tax assets
9.51%50.09M
30.39%50.01M
5.22%47.34M
13.01%42.56M
42.31%45.74M
36.99%38.35M
63.98%44.99M
59.48%37.66M
68.76%32.14M
26.67%28M
Usufruct assets
-50.64%5.72M
-83.78%2.04M
-81.98%2.45M
-80.45%2.87M
-13.61%11.58M
-5.85%12.57M
-4.01%13.59M
7.45%14.68M
-7.20%13.41M
53.94%13.35M
Other non current assets
556.96%133.81M
611.19%146.95M
840.58%146.18M
-61.42%20.26M
-52.63%20.37M
-40.47%20.66M
-58.22%15.54M
23.38%52.5M
-22.91%43M
-49.02%34.71M
Total non current assets
-30.44%1.38B
-29.49%1.38B
-28.50%1.4B
-9.28%1.8B
1.30%1.98B
-0.09%1.96B
-0.81%1.96B
-3.89%1.99B
-13.91%1.95B
-12.72%1.96B
Total assets
-1.77%8.02B
-2.48%7.99B
-2.54%7.83B
2.55%8.18B
4.03%8.17B
6.73%8.2B
5.40%8.03B
47.13%7.98B
48.65%7.85B
53.43%7.68B
Liabilities
Current liabilities
Notes payable and accounts payable
-39.66%138.49M
-63.22%115.83M
-58.36%126.35M
-52.77%140.92M
-32.41%229.51M
3.68%314.94M
9.34%303.46M
18.52%298.36M
28.87%339.58M
25.54%303.77M
-Notes payable
63.77%67.73M
19.36%48.19M
50.37%49.74M
24.05%38.03M
21.78%41.36M
-9.92%40.38M
-34.46%33.08M
-61.86%30.66M
-60.80%33.96M
-9.14%44.82M
-Accounts payable
-62.39%70.76M
-75.36%67.64M
-71.67%76.61M
-61.57%102.89M
-38.44%188.15M
6.03%274.57M
19.08%270.38M
56.23%267.7M
72.78%305.62M
34.43%258.95M
Contract liabilities
-29.13%5.79M
-26.91%8.15M
-40.68%12.21M
-67.58%5.86M
-12.53%8.18M
32.73%11.15M
58.59%20.58M
87.62%18.07M
-32.37%9.35M
-66.08%8.4M
Advance receipts
----
----
--110.56K
----
--2.14K
--4.29K
----
----
----
----
Salaries payable
-24.66%75.4M
-24.96%63.67M
-17.82%82.67M
61.40%89.61M
129.34%100.08M
153.17%84.85M
35.51%100.6M
24.86%55.52M
8.59%43.64M
-10.50%33.52M
Taxs payable
12.82%41.02M
-23.26%41.43M
-52.49%24.47M
-17.65%46.73M
-42.02%36.36M
30.80%53.98M
-18.12%51.5M
-5.74%56.75M
65.87%62.71M
-7.98%41.27M
Other payable (including interest and dividends)
-8.80%223.61M
-8.33%238.76M
3.36%208.65M
29.80%271.15M
28.81%245.19M
36.81%260.45M
2.51%201.86M
23.94%208.9M
16.49%190.35M
-0.92%190.38M
-Dividend payable
----
----
----
----
----
----
----
0.00%3.75M
----
----
-Other payable
-8.80%223.61M
----
3.36%208.65M
----
28.81%245.19M
----
2.51%201.86M
----
22.10%190.35M
----
Non current liabilities due within one year
799.69%22.96M
-69.11%871.31K
-96.37%907.05K
-96.81%777.87K
-89.54%2.55M
-88.35%2.82M
1,068.08%24.99M
-57.23%24.37M
-57.30%24.39M
-78.01%24.22M
Other current liabilities
-40.20%980.59K
-44.22%992.1K
-53.90%1.08M
-67.54%1.22M
-52.33%1.64M
-51.52%1.78M
-44.51%2.35M
394.40%3.76M
310.94%3.44M
165.51%3.67M
Total current liabilities
-18.49%508.25M
-35.65%469.71M
-35.29%456.45M
-16.44%556.27M
-7.42%623.51M
20.61%729.98M
11.79%705.34M
-20.01%665.73M
-17.53%673.45M
-8.67%605.22M
Current liabilities
Long term loan
----
--22.15M
--22.15M
--22.15M
--22.15M
----
----
----
----
----
Deferred tax liabilities
-17.11%4.42M
-17.52%4.49M
-17.91%4.56M
-6.43%5.23M
-6.41%5.34M
-6.38%5.45M
-6.36%5.56M
-12.09%5.58M
-11.90%5.7M
-11.71%5.82M
Long term deferred income
-14.02%21.51M
-13.58%22.52M
-13.17%23.52M
-11.13%24.99M
-14.17%25.02M
-13.68%26.05M
-12.57%27.09M
-6.53%28.12M
-5.84%29.15M
-4.40%30.18M
Lease liabilities
-56.68%3.9M
-85.61%1.4M
-86.47%1.4M
-86.38%1.62M
-19.25%9.01M
-10.01%9.76M
-8.25%10.37M
10.51%11.88M
0.45%11.16M
37.45%10.84M
Total non current liabilities
-51.49%29.84M
22.54%50.56M
20.03%51.63M
18.41%53.98M
33.69%61.51M
-11.93%41.26M
-38.87%43.01M
-34.25%45.58M
-34.91%46.01M
1.72%46.84M
Total liabilities
-21.45%538.09M
-32.54%520.26M
-32.11%508.07M
-14.21%610.25M
-4.79%685.02M
18.28%771.24M
6.71%748.35M
-21.10%711.32M
-18.91%719.46M
-8.00%652.06M
Shareholders equity
Paid-in capital
0.00%504.25M
0.00%504.25M
0.00%504.25M
0.00%504.25M
0.00%504.25M
-1.44%504.25M
-1.44%504.25M
16.37%504.25M
16.37%504.25M
18.07%511.63M
Capital reserve funds
-0.06%4.06B
-0.06%4.06B
-0.06%4.06B
0.07%4.07B
0.00%4.07B
-4.52%4.07B
-4.52%4.07B
108.82%4.07B
108.82%4.07B
118.71%4.26B
Surplus reserve funds
0.00%252.12M
0.00%252.12M
0.00%252.12M
8.18%252.12M
8.18%252.12M
8.18%252.12M
8.18%252.12M
19.76%233.06M
20.68%233.06M
20.68%233.06M
Retained profit
2.95%2.67B
4.67%2.65B
5.78%2.5B
15.12%2.73B
16.12%2.59B
18.98%2.53B
16.66%2.36B
15.91%2.37B
17.05%2.23B
16.05%2.13B
Less:Treasury stock
----
----
----
----
----
----
----
----
----
0.00%199.96M
Shareholders equity without minority interests
1.00%7.48B
1.57%7.47B
1.87%7.32B
5.30%7.55B
5.38%7.41B
6.11%7.36B
5.22%7.19B
61.68%7.17B
63.13%7.03B
64.73%6.93B
Minority interests
-98.88%807.58K
-98.83%810.88K
-98.92%1.07M
-78.23%21.01M
-27.48%71.85M
-26.93%69.2M
8.52%99.19M
11.72%96.52M
18.74%99.07M
7.89%94.7M
Total shareholder equity
0.04%7.49B
0.64%7.47B
0.49%7.32B
4.19%7.57B
4.92%7.48B
5.66%7.43B
5.26%7.28B
60.73%7.27B
62.29%7.13B
63.56%7.03B
Total liabilityies and equity
-1.77%8.02B
-2.48%7.99B
-2.54%7.83B
2.55%8.18B
4.03%8.17B
6.73%8.2B
5.40%8.03B
47.13%7.98B
48.65%7.85B
53.43%7.68B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 67.53%3.25B8.73%1.86B28.07%1.96B22.16%1.34B92.75%1.94B91.83%1.71B-3.29%1.53B1.48%1.1B39.13%1.01B33.36%891.97M
Transactional financial assets -26.44%2.24B15.00%3.71B5.28%3.36B7.89%3.77B-11.66%3.05B-5.16%3.22B18.29%3.19B271.41%3.49B263.73%3.45B--3.4B
Notes receivable and accounts receivable -29.57%322.24M-49.14%240.86M-54.56%209.84M-51.19%258.06M-20.01%457.52M-10.76%473.59M1.63%461.8M4.13%528.75M12.63%571.98M-6.30%530.68M
-Notes receivable --2.6M---------------------99.02%91.9K------------
-Accounts receivable -30.14%319.64M-49.14%240.86M-54.55%209.84M-51.19%258.06M-20.01%457.52M-10.76%473.59M3.74%461.71M12.36%528.75M32.76%571.98M13.29%530.68M
Other receivables (including interest and dividends) 278.34%191.11M81.96%154.41M162.77%264.4M324.51%354.26M-53.13%50.51M-6.79%84.86M48.20%100.62M36.19%83.45M74.29%107.77M72.27%91.04M
-Other receivable 278.34%191.11M----162.77%264.4M-----53.13%50.51M----48.20%100.62M----74.29%107.77M----
Advance payment -67.93%2.98M-58.98%2.62M-51.67%4.67M-36.20%3.43M130.49%9.29M-28.52%6.39M-25.75%9.66M-56.44%5.38M-63.08%4.03M-98.69%8.94M
Inventories -0.80%577.32M-8.30%566.51M-16.50%556.94M-11.76%579.7M-11.86%581.97M-7.83%617.82M-1.46%666.96M7.09%656.93M0.36%660.29M-2.49%670.31M
Receivable financing -41.02%58.46M-35.05%77.35M-37.20%66.08M-40.90%73.52M3.36%99.12M6.40%119.1M-21.28%105.22M2.56%124.41M11.30%95.91M32.18%111.94M
Other current assets -74.24%320.58K39.18%2.61M-50.82%1.77M-67.18%638.47K348.01%1.24M-87.80%1.88M-78.09%3.59M-87.48%1.95M-98.18%277.81K-2.63%15.37M
Total current assets 7.40%6.65B5.99%6.61B5.83%6.43B6.48%6.38B4.94%6.19B9.07%6.24B7.57%6.07B78.59%5.99B95.78%5.9B107.22%5.72B
Non Current assets
Other non-current financial assets -24.85%91M-22.76%92.37M-14.26%100.39M-10.68%111.84M-8.68%121.09M-12.50%119.59M-19.23%117.09M--125.21M--132.59M--136.67M
Investment real estate -7.52%623.83K-12.73%636.42K-7.30%649.01K--661.76K--674.52K--729.27K--700.08K------------
Fixed assets -1.66%607.7M-----0.88%634.23M-----9.60%617.95M-----10.67%639.88M-----5.18%683.59M----
Constru in process -38.87%55.27M-----42.41%39.94M----61.02%90.41M----69.72%69.34M-----14.17%56.15M----
Intangible assets -16.21%267.21M-13.80%265.81M-13.73%269.31M17.66%313.77M95.42%318.89M85.42%308.35M84.21%312.17M36.56%266.67M-15.15%163.19M-15.10%166.3M
Development expenditure 29.91%61.19M34.50%55.93M40.49%53.22M14.25%54.49M-59.09%47.1M-61.34%41.58M-63.32%37.88M-66.24%47.7M-13.89%115.14M-11.75%107.56M
Goodwill -89.06%72.61M-89.06%72.61M-89.06%72.61M-25.02%497.77M0.00%663.84M0.00%663.84M0.00%663.84M0.00%663.84M0.00%663.84M0.00%663.84M
Long deferred expense -23.87%31.32M-23.80%33.01M-21.95%34.93M7.47%50.53M-18.33%41.14M-20.25%43.32M-23.28%44.76M-20.53%47.02M-12.17%50.37M16.36%54.32M
Deferred tax assets 9.51%50.09M30.39%50.01M5.22%47.34M13.01%42.56M42.31%45.74M36.99%38.35M63.98%44.99M59.48%37.66M68.76%32.14M26.67%28M
Usufruct assets -50.64%5.72M-83.78%2.04M-81.98%2.45M-80.45%2.87M-13.61%11.58M-5.85%12.57M-4.01%13.59M7.45%14.68M-7.20%13.41M53.94%13.35M
Other non current assets 556.96%133.81M611.19%146.95M840.58%146.18M-61.42%20.26M-52.63%20.37M-40.47%20.66M-58.22%15.54M23.38%52.5M-22.91%43M-49.02%34.71M
Total non current assets -30.44%1.38B-29.49%1.38B-28.50%1.4B-9.28%1.8B1.30%1.98B-0.09%1.96B-0.81%1.96B-3.89%1.99B-13.91%1.95B-12.72%1.96B
Total assets -1.77%8.02B-2.48%7.99B-2.54%7.83B2.55%8.18B4.03%8.17B6.73%8.2B5.40%8.03B47.13%7.98B48.65%7.85B53.43%7.68B
Liabilities
Current liabilities
Notes payable and accounts payable -39.66%138.49M-63.22%115.83M-58.36%126.35M-52.77%140.92M-32.41%229.51M3.68%314.94M9.34%303.46M18.52%298.36M28.87%339.58M25.54%303.77M
-Notes payable 63.77%67.73M19.36%48.19M50.37%49.74M24.05%38.03M21.78%41.36M-9.92%40.38M-34.46%33.08M-61.86%30.66M-60.80%33.96M-9.14%44.82M
-Accounts payable -62.39%70.76M-75.36%67.64M-71.67%76.61M-61.57%102.89M-38.44%188.15M6.03%274.57M19.08%270.38M56.23%267.7M72.78%305.62M34.43%258.95M
Contract liabilities -29.13%5.79M-26.91%8.15M-40.68%12.21M-67.58%5.86M-12.53%8.18M32.73%11.15M58.59%20.58M87.62%18.07M-32.37%9.35M-66.08%8.4M
Advance receipts ----------110.56K------2.14K--4.29K----------------
Salaries payable -24.66%75.4M-24.96%63.67M-17.82%82.67M61.40%89.61M129.34%100.08M153.17%84.85M35.51%100.6M24.86%55.52M8.59%43.64M-10.50%33.52M
Taxs payable 12.82%41.02M-23.26%41.43M-52.49%24.47M-17.65%46.73M-42.02%36.36M30.80%53.98M-18.12%51.5M-5.74%56.75M65.87%62.71M-7.98%41.27M
Other payable (including interest and dividends) -8.80%223.61M-8.33%238.76M3.36%208.65M29.80%271.15M28.81%245.19M36.81%260.45M2.51%201.86M23.94%208.9M16.49%190.35M-0.92%190.38M
-Dividend payable ----------------------------0.00%3.75M--------
-Other payable -8.80%223.61M----3.36%208.65M----28.81%245.19M----2.51%201.86M----22.10%190.35M----
Non current liabilities due within one year 799.69%22.96M-69.11%871.31K-96.37%907.05K-96.81%777.87K-89.54%2.55M-88.35%2.82M1,068.08%24.99M-57.23%24.37M-57.30%24.39M-78.01%24.22M
Other current liabilities -40.20%980.59K-44.22%992.1K-53.90%1.08M-67.54%1.22M-52.33%1.64M-51.52%1.78M-44.51%2.35M394.40%3.76M310.94%3.44M165.51%3.67M
Total current liabilities -18.49%508.25M-35.65%469.71M-35.29%456.45M-16.44%556.27M-7.42%623.51M20.61%729.98M11.79%705.34M-20.01%665.73M-17.53%673.45M-8.67%605.22M
Current liabilities
Long term loan ------22.15M--22.15M--22.15M--22.15M--------------------
Deferred tax liabilities -17.11%4.42M-17.52%4.49M-17.91%4.56M-6.43%5.23M-6.41%5.34M-6.38%5.45M-6.36%5.56M-12.09%5.58M-11.90%5.7M-11.71%5.82M
Long term deferred income -14.02%21.51M-13.58%22.52M-13.17%23.52M-11.13%24.99M-14.17%25.02M-13.68%26.05M-12.57%27.09M-6.53%28.12M-5.84%29.15M-4.40%30.18M
Lease liabilities -56.68%3.9M-85.61%1.4M-86.47%1.4M-86.38%1.62M-19.25%9.01M-10.01%9.76M-8.25%10.37M10.51%11.88M0.45%11.16M37.45%10.84M
Total non current liabilities -51.49%29.84M22.54%50.56M20.03%51.63M18.41%53.98M33.69%61.51M-11.93%41.26M-38.87%43.01M-34.25%45.58M-34.91%46.01M1.72%46.84M
Total liabilities -21.45%538.09M-32.54%520.26M-32.11%508.07M-14.21%610.25M-4.79%685.02M18.28%771.24M6.71%748.35M-21.10%711.32M-18.91%719.46M-8.00%652.06M
Shareholders equity
Paid-in capital 0.00%504.25M0.00%504.25M0.00%504.25M0.00%504.25M0.00%504.25M-1.44%504.25M-1.44%504.25M16.37%504.25M16.37%504.25M18.07%511.63M
Capital reserve funds -0.06%4.06B-0.06%4.06B-0.06%4.06B0.07%4.07B0.00%4.07B-4.52%4.07B-4.52%4.07B108.82%4.07B108.82%4.07B118.71%4.26B
Surplus reserve funds 0.00%252.12M0.00%252.12M0.00%252.12M8.18%252.12M8.18%252.12M8.18%252.12M8.18%252.12M19.76%233.06M20.68%233.06M20.68%233.06M
Retained profit 2.95%2.67B4.67%2.65B5.78%2.5B15.12%2.73B16.12%2.59B18.98%2.53B16.66%2.36B15.91%2.37B17.05%2.23B16.05%2.13B
Less:Treasury stock ------------------------------------0.00%199.96M
Shareholders equity without minority interests 1.00%7.48B1.57%7.47B1.87%7.32B5.30%7.55B5.38%7.41B6.11%7.36B5.22%7.19B61.68%7.17B63.13%7.03B64.73%6.93B
Minority interests -98.88%807.58K-98.83%810.88K-98.92%1.07M-78.23%21.01M-27.48%71.85M-26.93%69.2M8.52%99.19M11.72%96.52M18.74%99.07M7.89%94.7M
Total shareholder equity 0.04%7.49B0.64%7.47B0.49%7.32B4.19%7.57B4.92%7.48B5.66%7.43B5.26%7.28B60.73%7.27B62.29%7.13B63.56%7.03B
Total liabilityies and equity -1.77%8.02B-2.48%7.99B-2.54%7.83B2.55%8.18B4.03%8.17B6.73%8.2B5.40%8.03B47.13%7.98B48.65%7.85B53.43%7.68B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data